Published mark
Sight Sciences, Inc.
NASDAQ: SGHT. Canonical company identity and public leadership record.
US
Record source reportedRecord not claimedNo Eval published
- Alpha ID
- alpha:company:a6ac990a-935c-4121-bd93-d5b4e286ab2a
- SEC CIK
- 0001531177
- Record version
- vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce, published Oct 9, 2026
- Newest evidence
- Apr 22, 2026
- Monitoring
- Not yet monitored Details
- Integrity
- Not yet signed Methodology
- CEO
- Paul BadawiSince Apr 22, 2026
- Chair
- Not published
- Independent
- 5 / 77 directors published
- Published claims
- 272 distinct sources
- Evidence records
- 90 pinned
- Source conflicts
- 0None open
Built from 2 distinct sources and 9 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.
CorroboratedSource reportedAlpha inferenceNot disclosed
Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works
EXECUTIVE APPOINTED
Alison Bauerlein executive of Sight Sciences, Inc., effective 2026-04-22.
EffectiveEffective Apr 22, 2026E3
Monitoring
ContinuousWhat the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.
- IdentityunclaimedPublished
- Evidencesource_reportedPublished
- Evaluationnot_evaluatedPublished
- MonitoringNot yet published for this record.Not published
- AuthorityNot yet published for this record.Not published
- FreshnesscurrentPublished
Leadership
Evidence| Role | Person | Since | Status | Claim |
|---|---|---|---|---|
| Chief Operating Officer | Alison Bauerlein | Apr 2026 | current | Source reportedE3 |
| Executive Vice President, Operations | Brenton Taylor | Apr 2026 | current | Source reportedE4 |
| Chief Technology Officer and Director | David Badawi, M.D. | Apr 2026 | current | Source reportedE5 |
| Chief Financial Officer and Treasurer | James Rodberg | Apr 2026 | current | Source reportedE6 |
| Chief Legal Officer | Jeremy Hayden | Apr 2026 | current | Source reportedE7 |
| President, Chief Executive Officer and Director | Paul Badawi | Apr 2026 | current | Source reportedE8 |
Board of directors
Evidence7 directors published. 5 of 7 with a published determination are independent.
| Director | Status | Since | Committees | Claim |
|---|---|---|---|---|
| Catherine Mazzacco | Independent | 2023 | AuditAudit; Nominating and Governance · ChairNominating and Governance, chair | Source reportedE2 |
| David Badawi, M.D. | Not independent | 2011 | None published | Source reportedE2 |
| Donald Zurbay | Independent | 2020 | Audit, chairAudit · Chair; CompensationCompensation | Source reportedE2 |
| Gerhard Burbach | Independent | 2025 | Compensation, chairCompensation · Chair; Nominating and GovernanceNominating and Governance | Source reportedE2 |
| Paul Badawi | Not independent | 2011 | None published | Source reportedE2 |
| Staffan Encrantz | Independent | 2017 | Audit | Source reportedE2 |
| Tamara Fountain, M.D. | Independent | 2022 | None published | Source reportedE2 |
Committees and risk ownership
Evidence| Committee | Chair | Members | Risks assigned |
|---|---|---|---|
| Audit | Donald Zurbay | Donald Zurbay, Catherine Mazzacco, Staffan Encrantz, Donald Zurbay, Catherine Mazzacco, Staffan Encrantz, Staffan Encrantz | Not described in the published record |
| Audit · Chair; Compensation | Not published | Donald Zurbay | Not described in the published record |
| Audit; Nominating and Governance · Chair | Not published | Catherine Mazzacco | Not described in the published record |
| Compensation | Gerhard Burbach | Gerhard Burbach, Donald Zurbay, Gerhard Burbach, Donald Zurbay | Not described in the published record |
| Compensation · Chair; Nominating and Governance | Not published | Gerhard Burbach | Not described in the published record |
| Nominating and Governance | Catherine Mazzacco | Catherine Mazzacco, Gerhard Burbach, Catherine Mazzacco, Gerhard Burbach | Not described in the published record |
Committee RecordAudit: Chair Donald Zurbay; Members Donald Zurbay (Chair); Catherine Mazzacco; Staffan Encrantz
Committee AppointmentDonald Zurbay: chair, Audit
Committee AppointmentCatherine Mazzacco: member, Audit
Committee AppointmentStaffan Encrantz: member, Audit
Committee RecordCompensation: Chair Gerhard Burbach; Members Gerhard Burbach (Chair); Donald Zurbay
Committee AppointmentGerhard Burbach: chair, Compensation
Committee AppointmentDonald Zurbay: member, Compensation
Committee RecordNominating and Governance: Chair Catherine Mazzacco; Members Catherine Mazzacco (Chair); Gerhard Burbach
Committee AppointmentCatherine Mazzacco: chair, Nominating and Governance
Committee AppointmentGerhard Burbach: member, Nominating and Governance
Control and voting power
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Authority to act
Evidence and agent registryWho can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.
Principal executive officerPaul Badawi, President, Chief Executive Officer and Director, from Apr 22, 2026
Who can authorize an agentNot assessedNo Alpha inference about signing authority or board-reserved matters is published for this record.
Not assessed
AI agents registered by the companyNot registered in the public RegistryAgent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
Agent registry
Delegations publishedNot disclosedBoard and officer delegation resolutions are not public filings and are not published in this record.
Search scope
Financials and market context
EvidenceSecurity ListingSGHT (NASDAQ)
Index membershipsNo current membership is published in Alpha's tracked index universe.This is not evidence that the company is absent from every market index.
None publishedAs of Oct 9, 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.
Governance and policies
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Risk, audit, and cyber
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
AI oversight and accountability
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Legal and regulatory
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Compensation
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Other published claims
EvidencePublished Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.
Legal NameSight Sciences, Inc.
Entity StatusPublic listing published
Published FactUS
Not yet in this record
CoverageA gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.
- Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
- OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
- FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
- CompensationNot reviewed. Pay design shows how incentives are governed.
- GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
- Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
- AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
- LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
- RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
- CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
- AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
- Markets externalNot reviewed. Auditors, advisors, investors and regulators form the external ecosystem.
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.
Linked people
Same claims as person records- Alison BauerleinChief Operating Officercompany:a6ac990a-935c-4121-bd93-d5b4e286ab2a:leadership_role:12
- Brenton TaylorExecutive Vice President, Operationscompany:a6ac990a-935c-4121-bd93-d5b4e286ab2a:leadership_role:13
- David Badawi, M.D.Chief Technology Officer and Directorcompany:a6ac990a-935c-4121-bd93-d5b4e286ab2a:leadership_role:14, company:a6ac990a-935c-4121-bd93-d5b4e286ab2a:leadership_role:6
- James RodbergChief Financial Officer and Treasurercompany:a6ac990a-935c-4121-bd93-d5b4e286ab2a:leadership_role:15
- Jeremy HaydenChief Legal Officercompany:a6ac990a-935c-4121-bd93-d5b4e286ab2a:leadership_role:16
- Paul BadawiPresident, Chief Executive Officer and Directorcompany:a6ac990a-935c-4121-bd93-d5b4e286ab2a:leadership_role:17, company:a6ac990a-935c-4121-bd93-d5b4e286ab2a:leadership_role:9
- Catherine MazzaccoDirectorcompany:a6ac990a-935c-4121-bd93-d5b4e286ab2a:leadership_role:5
- Donald ZurbayDirectorcompany:a6ac990a-935c-4121-bd93-d5b4e286ab2a:leadership_role:7
- Gerhard BurbachDirectorcompany:a6ac990a-935c-4121-bd93-d5b4e286ab2a:leadership_role:8
- Staffan EncrantzDirectorcompany:a6ac990a-935c-4121-bd93-d5b4e286ab2a:leadership_role:10
- Tamara Fountain, M.D.Directorcompany:a6ac990a-935c-4121-bd93-d5b4e286ab2a:leadership_role:11
Subject and corrections
Public-role doctrineThis record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.
- Basis
- Published company record built from public sources
- Sources
- 9 evidence records cited. 0 with redistribution rights.
- Never published
- Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
- Record claimed
- No
- Open disputes
- 0
- Identity ownership
- unclaimed
Claiming not yet available
If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.
Evidence
Authority and rights- E1Alpha canonical company public projection. canonical identity. Retrieved Oct 9, 2026. Cited by 4 Claims.
- E2sec proxy. Published Apr 22, 2026. Retrieved Apr 24, 2026. Cited by 7 Claims.
- E3sec filing. Published Apr 22, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
- E4sec filing. Published Apr 22, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
- E5sec filing. Published Apr 22, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
- E6sec filing. Published Apr 22, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
- E7sec filing. Published Apr 22, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
- E8sec filing. Published Apr 22, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
- E9board_seats. board seats. Cited by 10 Claims.
What changed in version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce
vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce published Oct 9, 2026- Alison Bauerlein executive of Sight Sciences, Inc., effective 2026-04-22.
- Brenton Taylor executive of Sight Sciences, Inc., effective 2026-04-22.
- David Badawi, M.D. executive of Sight Sciences, Inc., effective 2026-04-22.
- James Rodberg executive of Sight Sciences, Inc., effective 2026-04-22.
- Jeremy Hayden executive of Sight Sciences, Inc., effective 2026-04-22.
- Paul Badawi executive of Sight Sciences, Inc., effective 2026-04-22.
- Gerhard Burbach seat on Sight Sciences, Inc., effective 2025-01-01.
- Compensation · Chair; Nominating and Governance committee of Sight Sciences, Inc., effective 2025-01-01.
- Gerhard Burbach member of Compensation · Chair; Nominating and Governance, effective 2025-01-01.
- Catherine Mazzacco seat on Sight Sciences, Inc., effective 2023-01-01.
- Audit; Nominating and Governance · Chair committee of Sight Sciences, Inc., effective 2023-01-01.
- Catherine Mazzacco member of Audit; Nominating and Governance · Chair, effective 2023-01-01.
- Tamara Fountain, M.D. seat on Sight Sciences, Inc., effective 2022-01-01.
- Donald Zurbay seat on Sight Sciences, Inc., effective 2020-01-01.
- Audit · Chair; Compensation committee of Sight Sciences, Inc., effective 2020-01-01.
- Donald Zurbay member of Audit · Chair; Compensation, effective 2020-01-01.
- Staffan Encrantz seat on Sight Sciences, Inc., effective 2017-01-01.
- Staffan Encrantz member of Audit, effective 2017-01-01.
- David Badawi, M.D. seat on Sight Sciences, Inc., effective 2011-01-01.
- Paul Badawi seat on Sight Sciences, Inc., effective 2011-01-01.